Sign Up Today and Learn More About Abpro Stock
Invest in or calculate the value of your shares in Abpro or other pre-IPO companies through EquityZen's platform.
Abpro Stock (ABPR)
Abpro is a biotechnology company focused on therapeutics, diagnostics, and research.
About Abpro Stock
Founded
2007
Headquarters
Woburn, MA, US
Industries
Content and Publishing, Messaging and Telecommunications, Sports
Abpro is a biotechnology company dedicated to accelerating biological research by providing superior tools to researchers worldwide. As a pioneer of industrial biochemistry and an emerging leader in the reagents field, they have developed a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. As a result, Abpro delivers superior quality products at industry-leading speeds. Abpro leveraging these platforms, both independently and through collaborations with global pharmaceutical companies and research institutions to develop therapeutic antibodies for use in immuno-oncology, ophthalmology, and other disease areas. The DiversImmune platform enables the generation of novel antibodies and next-generation antibody therapies.
Abpro Press Mentions
Stay in the know about the latest news on Abpro
Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II
prnewswire • Nov 14, 2024
Abcuro Announces Participation in Upcoming Investor Conferences
businesswire • Nov 11, 2024
Celltrion, Cyron ink $882M deal for polyspecific antibodies
bioworld • Dec 19, 2023
Portage Fintech Acquisition Changes Name to Perception ...
news • Dec 19, 2023
Age-Related Macular Degeneration Market to Grow Rapidly ...
finance • Dec 19, 2023
Abpro Management
Leadership team at Abpro
CEO & CO-FOUNDER
Eugene Cha
SVP OF STRATEGIC ALLIANCES
John Xu
Join now and verify your accreditation status to gain access to:
- Abpro Current Valuation
- Abpro Stock Price
- Abpro Management
- Available deals in Abpro and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Abpro Cap Table and Funding History by Share Class and Liquidity Preferences
- Abpro Revenue and Financials
- Abpro Highlights
- Abpro Business Model
- Abpro Risk Factors
- Abpro Research Report from SACRA Research
Trading Abpro Stock
How to invest in Abpro stock?
Accredited investors can buy pre-IPO stock in companies like Abpro through EquityZen funds. These investments are made available by existing Abpro shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Abpro stock?
Shareholders can sell their Abpro stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."